Clinical Trials Logo

Breast Neoplasms clinical trials

View clinical trials related to Breast Neoplasms.

Filter by:

NCT ID: NCT02666378 Recruiting - Breast Cancer Clinical Trials

Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer

Start date: September 10, 2018
Phase:
Study type: Observational

This research study is evaluating the use of Cardiac Magnetic Resonance Imaging (CMR) as a method of detecting early signs of damage to the heart that can be associated with anthracycline-based chemotherapy for the treatment of breast cancer.

NCT ID: NCT02666261 Completed - Breast Cancer Clinical Trials

A Study on the Epidemiology and Testing of Human Epidermal Growth Factor-Receptor 2 (HER2) in Breast Cancer in Germany

Start date: March 4, 2016
Phase:
Study type: Observational

This non-interventional study will collect data from routine diagnostics on HER2 testing of breast cancer in Germany.

NCT ID: NCT02666079 Recruiting - Breast Cancer Clinical Trials

The LightPath® Breast Cancer Study

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

This study is a prospective, single arm, multi-centre study to evaluate the intra-operative use of the LightPath® Imaging System for the assessment of tumour margin status compared to hospital standard of care histopathology in wide local excision (WLE) for breast cancer The intraoperative 18F-fluorodeoxyglucose (18F-FDG) LightPath® Images will be used to inform the surgeons about detectable residual cancer, in an attempt to achieve better guided cancer surgery and complete tumour excision with clear WLE resection margins. Study sites will use the local criteria considered standard of care to guide decisions to act on positive margins. In the LightPath® arm the resection margin status of the WLE specimen, cavity shavings (if any) and the metastatic status of axillary (sentinel) lymph nodes as measured with the LightPath® Imaging System will be compared with histopathology results.

NCT ID: NCT02664662 Completed - Health Behavior Clinical Trials

Effectiveness of Tailored Rehabilitation Education on Health Literacy and Health Status of Postoperative Patients With Breast Cancer: a Randomized Controlled Trial

Start date: March 2016
Phase: N/A
Study type: Interventional

For the past few years, the survival rate of breast cancer improved due to the advancement of surgery techniques and popularization of cancer screening. However, prolonged survival rate is definitely not equal to achieving a sound quality of life among breast cancer survivors. The health status of cancer survivors might deteriorate according to the severe side effect of multiple therapies. Health literacy is the ability to access, understand, evaluate and communication information as a way to promote and maintain health. Therefore, good health literacy raise the quality of life of breast cancer survivors by a good competence in searching and using medical resources. Moreover, how to improve health literacy after cancer surgery becomes an important part recently. Even if the most fundamental concept has promoted for decades, the clinical workers still use the identical education of medical care after surgery for breast cancer survivors. However, the identical education is not appropriate for each of patients. In fact, each of breast cancer survivors has the different cancer stage leading to accept different therapy and producing different side effect. Besides, the background and the role of life are very different from each other. Because of the above reasons, the aim of the study is going to develop a tailored rehabilitated education, which fit for each breast cancer patients after surgery in clinic. At the same time, the health literacy ability might be improved by tailored rehabilitated education. When health literacy level is raised, the breast cancer survivors have a good quality of life and beautiful health status.

NCT ID: NCT02664103 Completed - Clinical trials for Breast Cancer Metastatic

Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast Cancer

METRO-ABC
Start date: January 23, 2016
Phase: Phase 2
Study type: Interventional

Primary Objectives: - To assess the safety for each cohort of patients on a fixed-dose combination pill of capecitabine and cyclophosphamide administered at flat dose and with metronomic schedule (defined as continuous daily treatment without interruption) in patients with metastatic breast cancer. - To assess the pharmacokinetics (PKs) and bioavailability of the fixed-dose combination pill of capecitabine and cyclophosphamide administered at different doses/regimens by metronomic schedule in patients with metastatic breast cancer. Secondary Objectives: - To assess antitumor activity of the fixed-dose combination pill of capecitabine and cyclophosphamide administered at different doses/regimens by metronomic schedule in patients with metastatic breast cancer given at 3 different doses and schedules (regimen 1=standard dose twice daily [BID], regimen 2=full dose once daily [OD], regimen 3=low dose [OD]) - Disease Control Rate (DCR) - Overall Response Rate (ORR) - Time to Progression (TTP) using the Response Evaluation Criteria in Solid Tumors (RECIST) criteria (version 1.1). - To evaluate the compliance under treatment. - To describe evolution of toxicities. - To assess safety all along patient's treatment.

NCT ID: NCT02663973 Completed - Breast Cancer Clinical Trials

Prospective Evaluation of Breast Cancer at Brazilian Institutions - Project AMAZONA III

Start date: January 1, 2016
Phase:
Study type: Observational

The principal goal of this study is to describe the epidemiology of breast cancer in the Brazilian population

NCT ID: NCT02662868 Completed - Clinical trials for Metastatic Breast Cancer

Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments

Start date: June 2015
Phase: N/A
Study type: Observational

The purpose of this study is to describe demographics and socioeconomics characteristics associated to the diagnosis of metastatic breast cancer in Brazil.

NCT ID: NCT02662335 Completed - Clinical trials for Stage IIIA Breast Cancer

Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors

Start date: May 2016
Phase: N/A
Study type: Interventional

This randomized clinical trial studies computerized cognitive retraining in improving cognitive function in breast cancer survivors. Cancer-related cognitive deficits, such as thinking and memory issues, are common among breast cancer survivors. The severity of these cognitive deficits is associated with a significant negative impact on daily function and quality of life. A computerized cognitive retraining method may help researchers find ways to improve cognitive function and quality of life in breast cancer survivors.

NCT ID: NCT02661932 Active, not recruiting - Breast Neoplasms Clinical Trials

Fertility Preservation in Breast Cancer Patients

Brovale
Start date: November 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate efficiency and safety of controlled ovarian stimulation (COS) associated with an aromatase inhibitor (letrozole) for fertility preservation in breast cancer patients.

NCT ID: NCT02659514 Completed - Breast Cancer Clinical Trials

Study of Poziotinib in Participants With HER2-Positive Metastatic Breast Cancer

Start date: February 22, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to establish the dose regimen and evaluate the preliminary efficacy and the safety/tolerability of poziotinib in participants with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer who have received at least two prior HER2-directed treatment regimens.